CTC Capital Management’s Chemed CHE Stock Holding History

CTC Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$255K	–	83
2022 Q4	$255K	Buy	+500	New	+$243K	0.3%	71

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

CTC Capital Management's CHE Position: Q1 2023 in Review

CTC Capital Management sold out of Chemed (CHE) in Q1 2023, closing a stake of 500 shares — an estimated $255K sold.

CTC Capital Management first reported a position in CHE in Q4 2022 and held it in 1 quarter. The position peaked at $255K in Q4 2022. 459 funds tracked by Wall St. Rank hold CHE as of Q1 2023.

CTC Capital Management reported no remaining Chemed position as of Q1 2023 after selling out during the quarter.
CTC Capital Management sold 500 Chemed shares in Q1 2023, an estimated $255K.
CTC Capital Management first reported a position in Chemed in Q4 2022 and held it in 1 quarter.
CTC Capital Management's Chemed position peaked at $255K in Q4 2022.
459 funds tracked by Wall St. Rank held Chemed as of Q1 2023.

Based on CTC Capital Management's 13F filing for Q1 2023, filed 5 May 2023.